Sponsored Links
| Advanced Skin Cancer Hope With Vemurafenib And Ipilimumab |
 |
 |
 |
| Medical News - Dermatology | |||
|
Patients with advanced melanoma may live longer with Ipilimumab, and have a better likelihood of surviving longer on Vemurafenib than chemotherapy, scientists revealed in the Annual Meeting of the American Society of Clinical Oncology (ASCO). In a phase three clinical trial, Vemurafenib was tested on 675 participants, all with advanced melanoma... Read more: Dermatology News From Medical News Today
|